Healthcare provider profile · identity verified

David R Polizzi

Family Practice · HAMPTON, NJ · NPI 1356349625

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	303	96
Levothyroxine Sodium	Levothyroxine Sodium	216	67
Amlodipine Besylate	Amlodipine Besylate	214	70
Lisinopril	Lisinopril	214	67
Zolpidem Tartrate	Zolpidem Tartrate	143	32
Metformin Hcl	Metformin Hcl	135	43
Alprazolam	Alprazolam	130	42
Metoprolol Succinate	Metoprolol Succinate	121	42
Rosuvastatin Calcium	Rosuvastatin Calcium	117	36
Omeprazole	Omeprazole	113	35
Simvastatin	Simvastatin	109	34
Gabapentin	Gabapentin	97	33
Sertraline Hcl	Sertraline Hcl	97	29
Prednisone	Prednisone	93	55
Tamsulosin Hcl	Tamsulosin Hcl	84	26
Albuterol Sulfate Hfa	Albuterol Sulfate	80	28
Lorazepam	Lorazepam	78	24
Carvedilol	Carvedilol	75	20
Hydrochlorothiazide	Hydrochlorothiazide	75	26
Trazodone Hcl	Trazodone Hcl	74	27
Meloxicam	Meloxicam	73	23
Losartan Potassium	Losartan Potassium	70	29
Fluoxetine Hcl	Fluoxetine Hcl	67	23
Glimepiride	Glimepiride	67	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	20
Paroxetine Hcl	Paroxetine Hcl	61	19
Pantoprazole Sodium	Pantoprazole Sodium	60	19
Metformin Hcl Er	Metformin Hcl	56	17
Oxycodone Hcl	Oxycodone Hcl	56	suppressed
Allopurinol	Allopurinol	54	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	14
Duloxetine Hcl	Duloxetine Hcl	51	14
Pravastatin Sodium	Pravastatin Sodium	51	16
Tramadol Hcl	Tramadol Hcl	47	16
Eliquis	Apixaban	46	12
Jardiance	Empagliflozin	46	12
Celecoxib	Celecoxib	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	14
Furosemide	Furosemide	43	15
Mounjaro	Tirzepatide	41	suppressed
Pregabalin	Pregabalin	41	suppressed
Cefuroxime	Cefuroxime Axetil	37	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	11
Azithromycin	Azithromycin	36	32
Montelukast Sodium	Montelukast Sodium	36	11
Potassium Chloride	Potassium Chloride	35	suppressed
Bupropion Xl	Bupropion Hcl	34	11
Synthroid	Levothyroxine Sodium	34	13
Clonazepam	Clonazepam	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	12
Warfarin Sodium	Warfarin Sodium	28	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	15
Atenolol	Atenolol	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Testosterone	Testosterone	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Ketoconazole	Ketoconazole	22	12
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Olanzapine	Olanzapine	19	suppressed
Ozempic	Semaglutide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	15
Diazepam	Diazepam	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Finasteride	Finasteride	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nystatin	Nystatin	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Digoxin	Digoxin	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Colchicine	Colchicine	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Belsomra	Suvorexant	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Clonidine Hcl	Clonidine Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glyburide	Glyburide	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Ropinirole Er	Ropinirole Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error